Dr. Barbara Kelly Changizi, MD

Dr. Changizi practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Changizi's NPI, 1609075175, was assigned on July 16, 2007. Dr. Changizi graduated from Duke University School Of Medicine in 2003. Dr. Changizi's Ohio license number on file is 35122578.

Dr. Changizi's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Changizi's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Changizi is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Changizi to 4 more hospitals and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Changizi practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Changizi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Changizi is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Changizi's licenses on file in 4 states: Ohio, Massachusetts, New York and California.

Dmand AI lists carpal tunnel syndrome, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, neuropathy, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Dr. Changizi treats.

CMS data shows 584 Medicare services from Dr. Changizi across 10 procedure codes in 2024, for 365 Medicare patients. Medicare paid $54,204 for them.

CMS counts 365 Medicare patients who saw Dr. Changizi in 2024. The largest group is 75 to 84, with 146 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Changizi's median patient age at 73, with 47% women.

In 2024, Dr. Changizi wrote 1,527 Medicare Part D claims for 254 patients. 90% of them were for generic drugs. CMS names the drug for 1,343 of them, across 29 drugs with 11 or more claims each, at $366,473 in total drug cost. In 2023, CMS named 1,177 claims across 27 drugs.

Dr. Changizi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Changizi as offering telehealth.

Dmand AI links 9 papers to Dr. Changizi, published from 2014 to 2022. 2021 was the busiest year, with 2. The most frequent topics are Deep Brain Stimulation and Essential Tremor. Dr. Changizi's most frequent co-authors are Vibhor Krishna, MD, Francesco Sammartino, MD and Kelly D. Foote, MD.

CMS Open Payments shows 34 general payments to Dr. Changizi from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Abbvie Inc. paid the most, $11,900.

Dr. Changizi graduated from Duke University School Of Medicine in 2003.

Dr. Changizi is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.